# Beta-blOckers discoNtinuation in Patients Presenting Heart FaIlure With REcovered Left Ventricular Ejection Fraction

> **NCT06518694** · PHASE3 · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 1300 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Βeta-Blockers discontinued (with tapering)

## Key facts

- **NCT ID:** NCT06518694
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-11
- **Primary completion:** 2027-10
- **Final completion:** 2027-10
- **Target enrollment:** 1300 (ESTIMATED)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06518694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06518694, "Beta-blOckers discoNtinuation in Patients Presenting Heart FaIlure With REcovered Left Ventricular Ejection Fraction". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06518694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*